Project

Exploiting novel GR biology as an opportunity to develop safer anti-inflammatory drugs

Acronym
SEGRM 2
Code
F2014/IOF-ADV/022
Duration
15 August 2014 → 31 March 2018
Funding
Regional and community funding: Industrial Research Fund
Research disciplines
  • Medical and health sciences
    • Biomarker discovery and evaluation
    • Drug discovery and development
    • Medicinal products
    • Pharmaceutics
    • Pharmacognosy and phytochemistry
    • Pharmacology
    • Pharmacotherapy
    • Toxicology and toxinology
    • Other pharmaceutical sciences
Keywords
selective drug discovery Glucocorticoid receptor agonist
 
Project description

Exploiting novel GR biology as an opportunity to develop safer anti-inflammatory drugs

For reasons of confidentiality the project summary cannot be disclosed.

For more information please contact the (co)promoter.